Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Non-Current Deffered Revenue: 2019-2023

Historic Non-Current Deffered Revenue for CureVac N.V (CVAC) over the last 5 years, with Dec 2023 value amounting to $51.8 million.

  • CureVac N.V's Non-Current Deffered Revenue fell 30.08% to $51.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $51.8 million, marking a year-over-year decrease of 30.08%. This contributed to the annual value of $51.8 million for FY2023, which is 30.08% down from last year.
  • CureVac N.V's Non-Current Deffered Revenue amounted to $51.8 million in FY2023, which was down 30.08% from $74.0 million recorded in FY2022.
  • In the past 5 years, CureVac N.V's Non-Current Deffered Revenue ranged from a high of $596.2 million in FY2020 and a low of $51.8 million during FY2023.
  • For the 3-year period, CureVac N.V's Non-Current Deffered Revenue averaged around $74.8 million, with its median value being $74.0 million (2022).
  • As far as peak fluctuations go, CureVac N.V's Non-Current Deffered Revenue surged by 715.63% in 2020, and later crashed by 83.43% in 2021.
  • CureVac N.V's Non-Current Deffered Revenue (Yearly) stood at $73.1 million in 2019, then soared by 715.63% to $596.2 million in 2020, then plummeted by 83.43% to $98.8 million in 2021, then fell by 25.07% to $74.0 million in 2022, then tumbled by 30.08% to $51.8 million in 2023.